Covered recipient · General Payments record
MARY CATHERINE MAYO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,166.49
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $829.64 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $406.49 | 15 |
| UCB, Inc. | $132.17 | 9 |
| Alexion Pharmaceuticals, Inc. | $87.39 | 3 |
| PFIZER INC. | $70.27 | 3 |
| Neurocrine BioSciences, Inc. | $60.02 | 2 |
| ACADIA Pharmaceuticals Inc | $29.28 | 1 |
| Ipsen Biopharmaceuticals, Inc | $28.43 | 1 |
| Acorda Therapeutics, Inc | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.28 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989480 | CMS |
| ABBVIE INC. | $29.25 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989482 | CMS |
| ABBVIE INC. | $33.62 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989484 | CMS |
| ABBVIE INC. | $26.63 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989486 | CMS |
| ABBVIE INC. | $21.34 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989488 | CMS |
| ABBVIE INC. | $34.21 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989490 | CMS |
| ABBVIE INC. | $28.52 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989492 | CMS |
| ABBVIE INC. | $25.82 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989494 | CMS |
| ABBVIE INC. | $33.65 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989496 | CMS |
| ABBVIE INC. | $32.12 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989498 | CMS |
| ABBVIE INC. | $17.28 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989500 | CMS |
| ABBVIE INC. | $29.67 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989502 | CMS |
| ABBVIE INC. | $9.97 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989504 | CMS |
| ABBVIE INC. | $31.04 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989506 | CMS |
| ABBVIE INC. | $29.09 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104989508 | CMS |
| ACADIA Pharmaceuticals Inc | $29.28 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147983826 | CMS |
| Acorda Therapeutics, Inc | $15.59 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142349130 | CMS |
| Alexion Pharmaceuticals, Inc. | $32.61 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094025723 | CMS |
| Alexion Pharmaceuticals, Inc. | $28.55 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094018046 | CMS |
| Alexion Pharmaceuticals, Inc. | $26.23 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094033628 | CMS |
| Ipsen Biopharmaceuticals, Inc | $28.43 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091992835 | CMS |
| Neurocrine Biosciences, Inc. | $32.58 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150822062 | CMS |
| Neurocrine Biosciences, Inc. | $27.44 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150832686 | CMS |
| PFIZER INC. | $27.54 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132118436 | CMS |
| PFIZER INC. | $21.35 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132125437 | CMS |
| PFIZER INC. | $21.38 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131212136 | CMS |
| UCB, Inc. | $12.98 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033637 | CMS |
| UCB, Inc. | $30.06 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033639 | CMS |
| UCB, Inc. | $0.86 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033641 | CMS |
| UCB, Inc. | $5.98 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033643 | CMS |
| UCB, Inc. | $6.42 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033645 | CMS |
| UCB, Inc. | $26.11 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143033647 | CMS |
| UCB, Inc. | $3.60 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029832 | CMS |
| UCB, Inc. | $25.54 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029834 | CMS |
| UCB, Inc. | $20.62 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143029836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.